BamSEC and AlphaSense Join Forces
Learn More

Matinas Biopharma Holdings Inc. – Indentures

NYSE American: MTNB    
Share price (6/3/26): $0.78    
Market cap (6/3/26): $4.984 million
Search in Documents
Key Exhibits
External Links

Indentures Filter

EX-4.2
from 10-K 5 pages Description of the Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
12/34/56
EX-4.4
from 10-Q 3 pages Omnibus Warrant Amendment
12/34/56
EX-4.2
from 10-K 5 pages Description of the Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
12/34/56
EX-4.2
from 8-K 20 pages Common Stock Purchase Warrant Matinas Biopharma Holdings, Inc
12/34/56
EX-4.6
from 10-Q 5 pages Description of the Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
12/34/56
EX-4.1
from 8-K 14 pages Common Stock Purchase Warrant Matinas Biopharma Holdings, Inc
12/34/56
EX-4.6
from 10-K 3 pages Description of the Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
12/34/56
EX-4.6
from S-3 54 pages Matinas Biopharma Holdings, Inc., as Issuer and ●, as Trustee Indenture Dated as of ● Subordinated Debt Securities Cross Reference Sheet1 Between
12/34/56
EX-4.5
from S-3 51 pages Matinas Biopharma Holdings, Inc., as Issuer and ●, as Trustee Indenture Dated as of ● Senior Debt Securities Cross Reference Sheet1 Between
12/34/56
EX-4.6
from 10-K 3 pages Description of the Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
12/34/56
EX-4.6
from 10-K 3 pages Description of the Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
12/34/56
EX-4.6
from 10-K 4 pages Description of the Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
12/34/56
EX-4.6
from S-3 54 pages Matinas Biopharma Holdings, Inc., as Issuer and ●, as Trustee Indenture Dated as of ● Subordinated Debt Securities Cross Reference Sheet1 Between
12/34/56
EX-4.5
from S-3 51 pages Matinas Biopharma Holdings, Inc., as Issuer and ● , as Trustee Indenture Dated as of ● Senior Debt Securities Cross Reference Sheet1 Between
12/34/56
EX-4.6
from 10-K 5 pages Description of the Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
12/34/56
EX-4.1
from 8-K 18 pages Form of Placement Agent’s Warrant Agreement
12/34/56
EX-4.6
from S-3 75 pages Matinas Biopharma Holdings, Inc., as Issuer and ●, as Trustee Indenture Dated as of ● Subordinated Debt Securities Cross Reference Sheet1 Between
12/34/56
EX-4.5
from S-3 70 pages Matinas Biopharma Holdings, Inc., as Issuer and ●, as Trustee Indenture Dated as of ● Senior Debt Securities Cross Reference Sheet1 Between
12/34/56
EX-4.1
from S-3 2 pages Indenture or similar
12/34/56
EX-4.1
from 10-K 2 pages Indenture or similar
12/34/56